Christine M. Dieckhaus
Christine M. Dieckhaus has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Carmen L. Fernández-Metzler
Department of Drug Metabolism, WP75-100, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486
1 shared publicationCharles D Thompson
1 shared publicationPaul H. Krolikowski
Department of Drug Metabolism, WP75-100, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486
1 shared publicationRichard King
Department of Drug Metabolism, WP75-100, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486
1 shared publication- Shane Roller
Jazz Pharmaceuticals, Palo Alto, CA
1 shared publication Thomas A. Baillie
Department of Drug Metabolism, WP75-100, Merck Research Laboratories, P.O. Box 4, Sumneytown Pike, West Point, Pennsylvania 19486
1 shared publication
Latest Publications
- 9 March 2005
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 18 (4) , 630-638
Negative Ion Tandem Mass Spectrometry for the Detection of Glutathione Conjugates
Characterization of S-linked conjugates of the endogenous tripeptide glutathione (γ-glutamyl-cysteinylglycine, GSH) represents a valuable indirect approach for the identification of chemically reactive, electrophilic intermediates formed during the metabolism of both foreign compounds and endogenous substances. In most cases, GSH adducts generated in vitro or excreted in the bile of animals are detected by the use of liquid chromatography−tandem mass spectrometry (LC−MS/MS), employing survey scans based on characteristic fragmentations of this class of conjugates. However, a limitation of current LC−MS/MS approaches, which typically employ electrospray ionization with analysis of positive ions, is that no single survey scan exhibits broad utility in the detection of unknown GSH adducts, since different structural classes of conjugate (aromatic, benzylic, aliphatic, thioester, etc.) behave differently upon collision-induced dissociation (CID) of the respective [M + H]+ parent ions. In the present study, we evaluated MS/MS in the negative ion mode as an alternative approach and report herein that the spectra obtained by CID of the [M − H]- ions of a number of representative GSH adducts, as well as GSH itself, are dominated by fragments originating from the glutathionyl moiety of the tripeptide. In particular, the anion at m/z 272, corresponding nominally to deprotonated γ-glutamyl-dehydroalanyl-glycine, was abundant in the negative ion spectra of free GSH and all GSH conjugates examined, suggesting that scanning for precursors of this ion may provide a generally applicable technique for the detection of adducts of unknown structure. The utility of this novel detection strategy was demonstrated in a series of in vitro and in vivo experiments where compounds known to undergo metabolic activation were examined for their propensity to form conjugates with GSH. In all cases, scanning for precursors of m/z 272 in the negative ion mode revealed the presence of the expected adducts and in some instances revealed additional conjugates that had not been reported previously. Positive ion MS/MS, on the other hand, was more useful than the corresponding negative ion scans in providing information on the molecular structure of GSH conjugates.
- 9 March 2005
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 18 (4) , 630-638
Negative Ion Tandem Mass Spectrometry for the Detection of Glutathione Conjugates
Characterization of S-linked conjugates of the endogenous tripeptide glutathione (γ-glutamyl-cysteinylglycine, GSH) represents a valuable indirect approach for the identification of chemically reactive, electrophilic intermediates formed during the metabolism of both foreign compounds and endogenous substances. In most cases, GSH adducts generated in vitro or excreted in the bile of animals are detected by the use of liquid chromatography−tandem mass spectrometry (LC−MS/MS), employing survey scans based on characteristic fragmentations of this class of conjugates. However, a limitation of current LC−MS/MS approaches, which typically employ electrospray ionization with analysis of positive ions, is that no single survey scan exhibits broad utility in the detection of unknown GSH adducts, since different structural classes of conjugate (aromatic, benzylic, aliphatic, thioester, etc.) behave differently upon collision-induced dissociation (CID) of the respective [M + H]+ parent ions. In the present study, we evaluated MS/MS in the negative ion mode as an alternative approach and report herein that the spectra obtained by CID of the [M − H]- ions of a number of representative GSH adducts, as well as GSH itself, are dominated by fragments originating from the glutathionyl moiety of the tripeptide. In particular, the anion at m/z 272, corresponding nominally to deprotonated γ-glutamyl-dehydroalanyl-glycine, was abundant in the negative ion spectra of free GSH and all GSH conjugates examined, suggesting that scanning for precursors of this ion may provide a generally applicable technique for the detection of adducts of unknown structure. The utility of this novel detection strategy was demonstrated in a series of in vitro and in vivo experiments where compounds known to undergo metabolic activation were examined for their propensity to form conjugates with GSH. In all cases, scanning for precursors of m/z 272 in the negative ion mode revealed the presence of the expected adducts and in some instances revealed additional conjugates that had not been reported previously. Positive ion MS/MS, on the other hand, was more useful than the corresponding negative ion scans in providing information on the molecular structure of GSH conjugates.
- 1 November 2002
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 142 (1-2) , 99-117
Mechanisms of idiosyncratic drug reactions: the case of felbamate
- 1 November 2002
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 142 (1-2) , 99-117
Mechanisms of idiosyncratic drug reactions: the case of felbamate